Nick and Marc Buoniconti hosted a dinner tonight honoring philanthropist extraordinaire Christine E. Lynn’s $10 million donation to name the Christine E. Lynn Human Clinical Trials Initiative at The Miami Project to Cure Paralysis. The contribution matches the largest gift ever given to the University of Miami Miller School of Medicine’s Miami Project.
The gift will not only name, but fund the human clinical trials initiative at The Miami Project. Research that is part of this initiative is in the translational phase and is being readied for clinic by undergoing the rigorous United States Food and Drug Administration (FDA) approval process. Currently, Miami Project researchers are in the process of seeking FDA approval for the first ever Phase 1clinical trial involving Schwann cell transplantation. These funds will go a long way in moving this important research forward and to laying an important foundation for future clinical trials.
“I have supported The Miami Project and The Buoniconti Fund for many years and it gives me great pride and pleasure to be a part of this most wonderful cause. I know how close they are to finding a cure for paralysis and I believe that when you have talent and support, miracles can happen. It gives me great satisfaction to name the Christine E. Lynn Human Clinical Trials Initiative at The Miami Project to Cure Paralysis,” said Mrs. Lynn.